Table 1

Patient characteristics are associated with socioeconomic status

12345P value
n=249n=373n=292n=347n=541
Male sex (% (n))77.1 (192)77.2 (288)71.2 (208)74.9 (260)68.6 (371)0.017
Age (years)71.4 (0.7)71.5 (0.6)70.9 (0.7)70.4 (0.7)66.3 (0.6)<0.001
NYHA class (% (n))0.11
 121.3 (53)19 (71)21.3 (62)15.3 (53)17.4 (94)
 255.8 (139)51.7 (193)48.5 (141)51.3 (178)48.3 (261)
 322.5 (56)27.9 (104)29.2 (85)31.4 (109)33.3 (180)
 40.4 (1)1.3 (5)1 (3)2 (7)0.9 (5)
Diabetes (% (n))22.9 (57)26.5 (99)29.1 (85)26.8 (93)31.4 (170)0.13
COPD (% (n))11.6 (29)12.3 (46)14.7 (43)20.2 (70)17.7 (96)0.009
Ischaemic CHF (% (n))61 (152)60.1 (224)57.5 (168)60.8 (211)57.7 (312)0.79
Systolic BP (mm Hg)118.6 (1.4)123.4 (1.2)125 (1.3)121.3 (1.4)122.7 (1)0.022
Heart rate (bpm)71.9 (1.1)76.4 (0.9)73.9 (1.2)75.2 (1)77 (0.8)0.003
QRS width (ms)124.5 (1.9)127.5 (1.8)125.2 (1.9)124.7 (1.8)117.6 (1.3)<0.001
Haemoglobin (g/dL)13.5 (0.1)13.5 (0.1)13.6 (0.1)13.4 (0.1)13.4 (0.1)0.72
eGFR (mL/min/1.73 m2)55.4 (1.1)56.7 (0.9)57.7 (1.1)56.8 (1.1)60.2 (0.9)0.006
LV ejection fraction (%)31.2 (0.6)31.8 (0.5)32.6 (0.6)31.9 (0.5)32.1 (0.4)0.54
Ramipril equivalent dose (mg)5.2 (0.2)5 (0.2)5.1 (0.2)4.5 (0.2)4.9 (0.2)0.17
Bisoprolol equivalent dose (mg)4.2 (0.2)4.1 (0.2)3.6 (0.2)3.7 (0.2)3.8 (0.1)0.09
Furosemide equivalent dose (mg)53.8 (3.2)50 (2.6)47.2 (2.5)53 (2.6)51.9 (2.3)0.5
Device therapy (% (n))36.9 (92)31.4 (117)28.4 (83)28.2 (98)21.1 (114)<0.001
IMD score (au)5.6 (0.1)11.2 (0.1)16.9 (0.1)27.8 (0.2)51.4 (0.4)<0.001
  • au denotes arbitrary units.

  • BP, blood pressure; CHF, chronic heart failure; COPD, chronic obstructive pulmonary disease; eGFR, estimated glomerular filtration rate; IMD, Index of Multiple Deprivation; LV, left ventricular; NYHA, New York Heart Association.